TheProfitWatch

MNKD - Mannkind Corporation

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.18 0.03 (0.58%) --- --- 0.0 (0.0%) -0.06 (-1.16%) 0.14 (2.75%) -0.05 (-0.95%) -0.05 (-0.95%)

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
0.0
Diluted EPS:
0.0
Basic P/E:
Diluted P/E:
RSI(14) 1m:
0.0
VWAP:
5.21
RVol:
0.7806

Events

Period Kind Movement Occurred At

Related News